The British Deny Health Care to the Non-Exceptional

Coming soon to a doctor's office near you, via the Obamacare Death Panels Independent Medicare Advisory Board. A British cancer patient has been denied a new cancer drug, that could add years to his life, because it doesn't represent a good value for the money.

A CANCER patient has been denied NHS funding for a new cancer drug which could add years to his life.

It means that health specialists will be unable to prescribe Everolimus, which costs about £40,000 a year and can extend lives by up to two years....